Trial Profile
A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vanycomycin in Adults With Primary Sclerosing Cholangitis
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 24 Apr 2024
Price :
$35
*
At a glance
- Drugs Vancomycin (Primary)
- Indications Primary sclerosing cholangitis
- Focus Therapeutic Use
- 17 Apr 2024 Planned End Date changed from 30 Nov 2024 to 30 Nov 2026.
- 17 Apr 2024 Planned primary completion date changed from 30 Oct 2024 to 30 Oct 2026.
- 09 Aug 2022 Planned End Date changed from 30 Nov 2022 to 30 Nov 2024.